Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00324597 | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00020644 | Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer | unknown | Phase 1 | — | Advocate Lutheran General HospitalOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | unknown | Phase 1 | 35 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00004173 | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer | unknown | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00009932 | Combination Chemotherapy in Treating Patients With Solid Tumors | unknown | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01806376 | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics | unknown | Phase 1 | 20 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Mar 8, 2013 | clinicaltrials |
| NCT01226407 | Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile | unknown | Phase 1 | 36 | CrystalGenomics, Inc.INDUSTRY | 1 | Dec 31, 2012 | clinicaltrials |
| NCT01724320 | A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors | unknown | Phase 1 | 20 | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 2 | Nov 9, 2012 | clinicaltrials |
| NCT01315431 | A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors | unknown | Phase 1 | 9 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00591292 | Phase I Study in Advanced Solid Tumors | unknown | Phase 1 | 22 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT01337310 | Study of Tesetaxel in Japanese Patients With Solid Tumors | unknown | Phase 1 | 12 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT01509300 | HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors | unknown | Phase 1 / Phase 2 | 10 | Asan Medical CenterOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01148628 | Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 54 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01155505 | Lenalidomide and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 28 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01159418 | LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 36 | Southern Europe New Drug OrganizationOTHER | 1 | Sep 13, 2011 | clinicaltrials |
| NCT00891280 | Dose-escalation Study of Oral CX-4945 | unknown | Phase 1 | 55 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01226030 | Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 21, 2010 | clinicaltrials |
| NCT01220284 | Satraplatin and Vinorelbine in Advanced Solid Tumors | unknown | Phase 1 | 27 | Southern Europe New Drug OrganizationOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT01166035 | Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors(TEXO) | unknown | Phase 1 / Phase 2 | 20 | Medical University InnsbruckOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT00003073 | Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors | unknown | Phase 1 | 15 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Mar 23, 2010 | clinicaltrials |
| NCT00544063 | Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer | unknown | Phase 1 | 33 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00710697 | Cardiac Safety Assessment Study of Picoplatin in Solid Tumors | unknown | Phase 1 | 40 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00004063 | Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer | unknown | Phase 1 / Phase 2 | 30 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00881101 | Clinical Study of Liposomal Paclitaxel in Chinese Patients | unknown | Phase 1 | 15 | Nanjing Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00005611 | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Jul 24, 2008 | clinicaltrials |
| NCT00657176 | An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 36 | Korea Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00262327 | Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Jun 20, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Sep 17, 2013source: clinicaltrials